PubRank

F Lupu

Author PubWeight™ 81.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999 7.33
2 Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 1999 4.85
3 Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001 4.66
4 Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 1999 4.33
5 Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997 3.40
6 Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost 2005 2.70
7 Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001 2.66
8 Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol 1996 2.08
9 Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 2001 2.06
10 Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation 1997 1.91
11 Hyperexcitability of convergent colon and bladder dorsal root ganglion neurons after colonic inflammation: mechanism for pelvic organ cross-talk. Neurogastroenterol Motil 2006 1.51
12 Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 1998 1.48
13 Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am J Pathol 1986 1.45
14 Rings of membrane sterols surround the openings of vesicles and fenestrae, in capillary endothelium. J Cell Biol 1983 1.40
15 Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010 1.39
16 In vivo detection of c-Met expression in a rat C6 glioma model. J Cell Mol Med 2007 1.25
17 Innate immunity and coagulation. J Thromb Haemost 2011 1.24
18 Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res 2000 1.18
19 Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol 1997 1.11
20 An endothelial storage granule for tissue-type plasminogen activator. J Cell Biol 1997 1.10
21 Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res 2000 1.08
22 Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 2000 1.07
23 Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res 1997 1.06
24 Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. Arterioscler Thromb Vasc Biol 1999 1.06
25 Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol 1995 1.03
26 Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J Cell Biol 1998 1.03
27 Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: A potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes. Arterioscler Thromb Vasc Biol 2000 0.99
28 Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Blood 2000 0.99
29 Adipose tissue expression of gelatinases in mouse models of obesity. Thromb Haemost 2001 0.96
30 Distinct localization and function of (1,4,5)IP(3) receptor subtypes and the (1,3,4,5)IP(4) receptor GAP1(IP4BP) in highly purified human platelet membranes. Blood 2000 0.95
31 Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler Thromb Vasc Biol 1997 0.95
32 Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaques. J Thromb Haemost 2006 0.94
33 Release of soluble urokinase receptor from vascular cells. Thromb Haemost 2001 0.91
34 Prelesional events in atherogenesis. Colocalization of apolipoprotein B, unesterified cholesterol and extracellular phospholipid liposomes in the aorta of hyperlipidemic rabbit. Atherosclerosis 1987 0.87
35 Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Arterioscler Thromb Vasc Biol 1997 0.86
36 Prelesional modifications of the vessel wall in hyperlipidemic atherogenesis. Extracellular accumulation of modified and reassembled lipoproteins. Ann N Y Acad Sci 1990 0.86
37 In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels. Thromb Haemost 2000 0.84
38 Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells. Thromb Haemost 1995 0.84
39 Fluid flow induces upregulation of synthesis and release of tissue factor pathway inhibitor in vitro. Arterioscler Thromb Vasc Biol 2000 0.84
40 Temporal and topographic matrix metalloproteinase expression after vascular injury in mice. Thromb Haemost 1999 0.84
41 Polymorphism of HLA in the Romanian population. Tissue Antigens 1992 0.84
42 Cellular events in the development of valvular atherosclerotic lesions induced by experimental hypercholesterolemia. Atherosclerosis 1987 0.83
43 Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons. Thromb Haemost 1999 0.82
44 A novel L23-related gene 40 kb downstream of the imprinted H19 gene is biallelically expressed in mid-fetal and adult human tissues. Hum Mol Genet 1995 0.82
45 Population and family studies of HLA-DR4 by use of oligonucleotide typing. Tissue Antigens 1992 0.82
46 Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia. J Thromb Haemost 2013 0.79
47 Organization of the intercellular junctions in the endothelium of cardiac valves. J Submicrosc Cytol 1985 0.79
48 Cytochemical localization of beta-lipoproteins and their components in successive stages of hyperlipidemic atherogenesis of rabbit aorta. Atherosclerosis 1989 0.79
49 Changes in the organization of membrane lipids during human platelet activation. Study by fluorescent and freeze-fracture cytochemistry. Lab Invest 1986 0.78
50 Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation. Gene Ther 1999 0.78
51 Differentiation-stage specific self-peptides bound by major histocompatibility complex class I molecules. J Exp Med 1993 0.78
52 Enhanced prothrombin and intrinsic factor X activation on blood platelets from diabetic patients. Thromb Haemost 1993 0.78
53 CD9 gene deficiency does not affect smooth muscle cell migration and neointima formation after vascular injury in mice. Thromb Haemost 2000 0.78
54 Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro. Thromb Haemost 2001 0.78
55 Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aalpha-chain, alters endothelial capillary tube formation. Blood 2001 0.77
56 In vivo targeted molecular magnetic resonance imaging of free radicals in diabetic cardiomyopathy within mice. Free Radic Res 2015 0.76
57 High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid-DNA complex. Gene Ther 1997 0.76
58 4-Hydroxynonenal induces membrane perturbations and inhibition of basal prostacyclin production in endothelial cells, and migration of monocytes. Cell Biol Int 1994 0.76
59 A new class of potential carcinogenesis inhibitors: hindered p-benzoquinones. Neoplasma 1991 0.75
60 In vitro screening of carcinogenesis inhibitors acting by inhibition of microsomal polycyclic aromatic hydrocarbon activation. Neoplasma 1987 0.75
61 Influence of the membrane undercoat on filipin perturbation of the red blood cell membrane. Exp Cell Res 1987 0.75
62 [Paramedical personnel in emergency care in accidents]. Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit 1990 0.75
63 Prothrombin cleavage by human vascular smooth muscle cells: a potential alternative pathway to the coagulation cascade. J Cell Biochem 1995 0.75
64 Mechanisms of cancerogenesis inhibition. II. The aminophenols and their oxidation products. Neoplasma 1988 0.75